California State Teachers Retirement System Has $1.06 Million Stock Position in LifeStance Health Group, Inc. $LFST

California State Teachers Retirement System increased its stake in LifeStance Health Group, Inc. (NASDAQ:LFST) by 32.1% during the first quarter, HoldingsChannel reports. The firm owned 166,084 shares of the company’s stock after acquiring an additional 40,402 shares during the period. California State Teachers Retirement System’s holdings in LifeStance Health Group were worth $1,058,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Larson Financial Group LLC grew its position in LifeStance Health Group by 19,952.6% during the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after purchasing an additional 3,791 shares in the last quarter. KBC Group NV acquired a new stake in LifeStance Health Group during the first quarter valued at $29,000. Bayesian Capital Management LP bought a new stake in shares of LifeStance Health Group in the 2nd quarter valued at approximately $52,000. PNC Financial Services Group Inc. increased its holdings in LifeStance Health Group by 615.3% in the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock worth $59,000 after buying an additional 7,987 shares during the last quarter. Finally, Assetmark Inc. raised its holdings in shares of LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock valued at $60,000 after purchasing an additional 1,367 shares in the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other LifeStance Health Group news, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $10.62, for a total value of $144,890,858.34. Following the completion of the sale, the insider owned 98,101,407 shares of the company’s stock, valued at $1,041,836,942.34. The trade was a 12.21% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Lisa K. Miller sold 47,912 shares of the firm’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $10.85, for a total transaction of $519,845.20. Following the completion of the transaction, the chief operating officer directly owned 281,289 shares in the company, valued at approximately $3,051,985.65. This represents a 14.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 14,629,850 shares of company stock valued at $154,952,012 over the last quarter. 3.50% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. The Goldman Sachs Group began coverage on LifeStance Health Group in a report on Friday, June 5th. They issued a “neutral” rating and a $9.00 target price for the company. Weiss Ratings upgraded shares of LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday. JPMorgan Chase & Co. upped their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company a “neutral” rating in a research report on Friday. BTIG Research boosted their price objective on LifeStance Health Group from $15.00 to $16.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Finally, Barclays upped their target price on LifeStance Health Group from $9.00 to $13.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, LifeStance Health Group presently has an average rating of “Moderate Buy” and an average price target of $12.12.

LifeStance Health Group Trading Up 1.6%

LFST opened at $12.42 on Friday. LifeStance Health Group, Inc. has a twelve month low of $4.77 and a twelve month high of $12.76. The firm’s fifty day moving average is $10.39 and its two-hundred day moving average is $8.22. The firm has a market cap of $4.82 billion, a PE ratio of 95.55 and a beta of 1.14. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The firm had revenue of $435.35 million for the quarter, compared to analyst estimates of $414.58 million. During the same quarter in the previous year, the firm posted ($0.01) earnings per share. The business’s revenue was up 26.1% on a year-over-year basis. Equities research analysts anticipate that LifeStance Health Group, Inc. will post 0.15 EPS for the current year.

LifeStance Health Group Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.